Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery
European Journal of Nuclear Medicine and Molecular Imaging · 2026-02 · 53 (3) · 1765-1781
DOI: 10.1007/s00259-025-07573-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 24.09.2025. Verfasst von Linjie Bian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai…. Hauptthemen laut MEDLINE: Uridine, Positron Emission Tomography Computed Tomography, Precision Medicine, Optical Imaging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: the State Key Program of the National Natural Science Foundation of China, Shanghai Scientific and Technological Innovation Program, National Isotope Engineering Technology Research Center Funding.
Abstract (Originalsprache)
PURPOSE: Metabolic reprogramming allows cancer cells to survive and proliferate under nutrient-deprived conditions. Uridine, a central molecule in pyrimidine metabolism, supports both nucleotide biosynthesis and redox homeostasis. However, high-sensitivity imaging tools for equilibrative nucleoside transporter 1 (ENT1)-mediated uridine transport are lacking, limiting applications in precise diagnosis and intraoperative guidance. This study aimed to develop and validate a novel dual-modality imaging platform targeting ENT1-mediated uridine transport for tumor imaging and surgical navigation. METHODS: We synthesized [68Ga]Ga-DOTA-FZUD and ICG-FZUD probes for PET and NIR-II fluorescence imaging, respectively. Small-animal PET/CT and NIR-II fluorescence imaging were performed, and biodistribution were analyzed. Ex vivo NIR-II fluorescence imaging using ICG-FZUD was performed on surgical specimens from three gastric cancer patients to confirm tumor targeting. RESULTS: [68Ga]Ga-DOTA-FZUD exhibited excellent radiochemical purity. In pancreatic cancer models with relatively higher ENT1 expression (AsPC-1, Panc-1) compared with lower ENT1 expression models (MiaPaCa-2, BxPC-3), [68Ga]Ga-DOTA-FZUD demonstrated markedly greater tumor uptake. Similar uptake was also observed in gastric, breast, and glioblastoma models, with tumor-to-muscle ratios consistently exceeding 3.5. ICG-FZUD enabled high-contrast NIR-II imaging and clearly delineated tumor margins. Notably, ICG-FZUD penetrated the blood-brain barrier and visualized orthotopic glioblastoma. Ex vivo imaging of human gastric cancer tissues confirmed selective tumor uptake, consistent with histopathological findings. CONCLUSION: This ENT1-targeted uridine transport PET/NIRF dual-modality imaging platform complements conventional glucose-based imaging and provides real-time intraoperative navigation. It holds significant promise for early cancer diagnosis and precision surgery with strong translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
- Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, China.
- Center for Biomedical Imaging, Fudan University, Shanghai, 200032, China.
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University, Shanghai, 200433, China.
- Department of General Surgery, The Affiliated Wuxi Central Hospital of Jiangnan University, Wuxi, Jiangsu, 214100, China.
- Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. jindianli99@126.com.
ORCID-Profile: Shaoli Song
Förderung
- the State Key Program of the National Natural Science Foundation of China
- Shanghai Scientific and Technological Innovation Program
- National Isotope Engineering Technology Research Center Funding
- the construction project of Shanghai Key Laboratory of Molecular Imaging
- Shanghai Pujiang Program
Zitieren
APA
Bian, L., Li, P., Chen, Y., He, S., Zhang, J., Xu, X., Li, J., & Song, S. (2026). Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery. European Journal of Nuclear Medicine and Molecular Imaging, 53(3), 1765-1781. https://doi.org/10.1007/s00259-025-07573-9
Vancouver
Bian L, Li P, Chen Y, He S, Zhang J, Xu X, et al. Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(3):1765-1781. doi:10.1007/s00259-025-07573-9
BibTeX
@article{Bian2026,
author = {Bian, Linjie and Li, Panli and Chen, Yigang and He, Simin and Zhang, Jianping and Xu, Xiaoping and Li, Jindian and Song, Shaoli},
title = {Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {3},
pages = {1765--1781},
doi = {10.1007/s00259-025-07573-9}
}
EUVIMED